Clinical Trial Update: A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder [Phase 4]

View source ↗

Summary

This document summarizes the completion of a Phase 4 double-blind randomized trial comparing galantamine hydrobromide to placebo in adults with ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Galantamine HBr (galantamine hydrobromide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: ADHD | Phase 4 | Status: COMPLETED